UNSPSC 41202025: Escherichia coliserological reagents

In this classification, Escherichia coli serological reagents are devices used in test to identify specific Escherichia coli antibodies in serum. US FDA regulates Escherichia coli serological reagents under 21 CFR 866.3255 and under FDA product code GMZ.

UNSPSC 41202025 Escherichia coli serological reagents is a Commodity code tracking state and local procurement of diagnostic testing supplies and reagents for infectious disease screening, particularly sexually transmitted infection (STI) testing, HIV testing, and related laboratory diagnostics. The actual procurement activity centers on rapid test kits, analyzer-compatible reagents, calibrators, controls, and consumables used in high-volume public health and criminal justice laboratory operations. State and local health departments, county corrections and community supervision agencies, and municipal public health programs solicit under this code to maintain diagnostic capacity for STI, HIV, and Syphilis testing tied to public health surveillance, offender monitoring, and disease control missions. Illinois Department of Public Health and Collin County emerge as repeat buyers in recent solicitations.

Recent activity spans Illinois, Texas, and Georgia. The Illinois Department of Public Health issued an emergency procurement for Abbott HIV and Syphilis reagents in May 2026 (26482DPHFINANB52340) with execution May 5–19, 2026, followed by a second emergency notice in May 2026 (26482DPHOFCDIB52638) due August 18, 2026; both secured sole-source Abbott reagent kits and maintenance services at $38,079.50 total. More substantially, Illinois IDPH posted a change order notice (27482DPHOFCDIB53956) on September 29, 2026, increasing annual NG/CT testing from 15,000 to 25,000 tests and collection kits from 15,000 to 30,000 units under a five-year Hologic reagent rental agreement, raising the contract cost by $375,000 to $900,000 total (response due October 13, 2026). Collin County, Texas issued an RFP for offender specimen collection and drug testing services (2026-327) posted September 25, 2026 with an approximate $600,000 annual contract value covering immunoassay screening and confirmatory testing across two sites, closing July 23, 2026. The City of Austin posted two competitive IFBs for rapid HIV test kits (IFB 9100 AAM1023 in June 2026 and a rebid IFB 9100 AAM1023REBID in August 2026) for approximately 375 test kits and 79 control kits annually. Gwinnett County, Georgia issued a brief RFP for drug testing supplies compatible with an existing analyzer (PE77023NONST2027000000764) due October 14, 2026, with minimal detail available.